A Systematic Review and Meta-Analysis of the Inflammatory Biomarkers in Mild Traumatic Brain Injury

• Published in: Biomedicines Vol. 12; no. 2; p. 293
• Main Authors: Mavroudis, Ioannis, Ciobica, Alin, Balmus, Ioana Miruna, Burlui, Vasile, Romila, Laura, Iordache, Alin
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01.01.2024
• Subjects: Analysis; B cells; Bias; Biological markers; Biomarkers; Brain; Chemokines; Clinical outcomes; Concussion; Cytokines; diagnosis; Inflammation; Interleukins; Meta-analysis; mild traumatic brain injury; Morbidity; neuroinflammation; outcomes; Pathogenesis; Pathophysiology; Plasma levels; post-concussion syndrome; proinflammatory cytokines; Protein expression; Proteins; Traumatic brain injury; Tumor necrosis factor-TNF; Tumor necrosis factor-α; Type 2 diabetes; Romania; proinflammatory cytokines; neuroinflammation; outcomes; diagnosis; recovery; post-concussion syndrome; mild traumatic brain injury
• ISSN: 2227-9059; 2227-9059
• DOI: 10.3390/biomedicines12020293

Mild traumatic brain injury (mTBI) accounts for most TBI cases, the leading cause of morbidity and mortality worldwide. Despite its high incidence, mTBI pathophysiology remains largely unknown. Recent studies have shown that the inflammatory response is activated early after mTBI and can persist for several weeks or months. However, limited evidence on the utility of inflammatory biomarkers as predictors of clinical outcomes in mTBI has been previously provided. Thus, this systematic review and meta-analysis aims to provide an overview of the current knowledge on the role of inflammation in the pathogenesis of mTBI and the potential of some inflammatory biomolecules as biomarkers of mTBI. In this regard, eight studies comprising 1184 individuals were selected. Thus, it was shown that the increase in IL-6, TNF-α, and IL-1β plasma levels could be implicated in the development of early post-concussion symptoms. On the other hand, the persistence of the increased plasmatic concentrations of IL-10 and IL-8 for as long as six months following the brain injury event could suggest chronic inflammation leading to neuroinflammation and late or persistent symptoms. In this context, our findings showed that inflammatory biomarkers could be relevant in diagnosing or predicting recovery or long-term outcomes of mTBI.